Objective: Exposure to high levels of air pollutants may be linked to diabetes-associated mortality, but the associations remain unclear. To assess the associations between main air pollutants and diabetes-associated mortality, a systematic review and meta-analysis was performed. Methods: PubMed, Embase and Web of Science were searched for studies investigating the associations between increments in gaseous (nitrogen dioxide (NO 2 ), sulphur dioxide, ozone (O 3 ) and carbon monoxide) and particulate matter (PM; diameter !2.5 mm (PM2.5) or !10 mm (PM10)) air pollutants and diabetes-associated mortality. Using a random-effects model, relative risks (RRs) and 95% CIs were calculated per interquartile range (IQR) increment or per 10 mg/m 3 increment in pollutant concentrations.
Introduction
Diabetes mellitus is a serious public health issue worldwide and has caused serious damages to public health (1, 2) . There were over 366 million people diagnosed with diabetes mellitus worldwide in 2011 (3, 4) . Though obesity is a major risk factor leading to increasing incidence of type 2 diabetes, other potential risk factors have been proposed, such as air pollution (5, 6) . Air pollution is a more and more serious problem worldwide, and one in of exposures to air pollution have included diabetesassociated mortality, although it has not been the primary focus in most analyses (12, 13, 14, 15, 16, 17, 18, 19, 20) . We therefore systematically reviewed the evidence examining the association between air pollution and diabetes-associated mortality. In the present metaanalysis, we focused on the associations between increments in gaseous (nitrogen dioxide (NO 2 ), sulphur dioxide (SO 2 ), ozone (O 3 ) and carbon monoxide (CO)) and particulate matter (PM, diameter !2.5 mm (PM2.5) or !10 mm (PM10)) air pollutants and diabetes-associated mortality. This study is registered in the International Prospective Register of Systematic Reviews (PROSPERO), number CRD42014009162.
Methods

Search strategy and study selection
Pubmed, Embase and Web of Science were searched for observational studies assessing the associations of diabetes-associated mortality with increments in gaseous (NO 2 , SO 2 , O 3 and CO) and particulate (PM2.5 and PM10) air pollutants. We also searched abstracts from the 2012 and 2013 meetings of the American Diabetes Association and the European Association for the Study of Diabetes. The search time was from their commencements to February 26, 2014 , and there was no language restriction. The following keywords were used: 'diabetes', 'diabetic', 'air pollution', 'particulate matter', 'PM2.5', 'PM10', 'sulphur dioxide', 'ozone', 'carbon monoxide' and 'nitrogen dioxide'. Hand searching of selected journals and checking of bibliographies in relevant published reviews or articles were also performed to supplement the electronic searches. After removal of duplicate references, initial screening of titles and abstracts was performed by two members of the review team. Potentially relevant articles were obtained in full text and assessed independently by two members of the review team. Any disagreements were settled by discussion among all members of the review team.
The inclusion criteria were as following: i) casecrossover, time-series, nested case-control, or cohort studies; ii) estimation of the effect of exposures to air pollution, including gaseous (NO 2 , SO 2 , O 3 and CO) and particulate (PM2.5 and PM10) air pollutants, on diabetesassociated mortality; iii) the outcome was diabetesassociated mortality; iv) reported relative risks (RRs) or hazard ratios with 95% CIs for diabetes-associated mortality, or other sufficient data to estimate these data.
Case-control and cross-sectional studies were all excluded. In addition, studies without usable data or of low quality were also excluded. For multiple reports from the same study, only the article with the largest dataset for identical outcomes was included.
Data extraction and quality assessment
Data were extracted independently by two investigators and conflicts were adjudicated by a third investigator. There was an agreement value (k) of 94% in the studies selected by these two investigators for detailed analysis. Data extraction using a standardised form included a full description of the study characteristics: first author, publication year, country, ethnic origin, study design, baseline characteristics, exposure type, data type, events of diabetes-associated mortality, adjustments in analyses and adjusted RRs with 95% CIs. This study collected data for maximally adjusted risk estimates, if available. We contacted authors for additional data or clarification where needed.
As there were no validated scales to evaluate the methodological quality of time-series studies and casecrossover studies, we used a quality scale that was based on validated scales for other types of epidemiological studies and used in the study by Mustafic et al. (9) . We evaluated three components (the validation of diabetes-associated mortality (0-1 point), the quality of air pollutant measurements (0-1 point) and the extent of adjustment for confounders (0-3 points)) (9) . Quality was graded as excellent with five points, good with 3-4 points and suboptimal with 0-2 points. Only studies with excellent or good quality were finally included into the analysis.
Statistical methods
We used RR as a measure of effect size because it was an intuitive and commonly used measure in the medical and public health literature. Many studies used generalised linear models and, therefore, we assumed a linear relation between exposure and outcome, and RRs were further expressed for a standardised increment in the pollutant concentration by 10 mg/m 3 each for PM2.5, PM10 and NO 2 . Standardised risk estimates were calculated for each study using the following formula: RR (standardised) ZRR (original) increment(10)/increment(original) (8) . The pooled RRs with 95% CIs were calculated using a random-effects model for all analyses (21) . The significance of the pooled RR was determined by the Z test and a P value of !0.05 was considered significant. Statistical (23) . In addition, the trim and fill method was also used to simulate those studies that may be missing from the literature, and we estimated the pooled RR after adding those 'missing' studies (24) . Statistical analyses were performed using Stata 12.0 (StataCorp, College Station, TX, USA). Statistical significance was taken as two-sided P!0.05.
Results
Literature search and study characteristics
The abstracts of 925 articles were assessed, and 36 studies were selected for in-depth review, with 23 studies not fulfilling the inclusion criteria ( Fig. 1 ). Two articles evaluated three different pollutants from the same study (12, 25) . Thus, 12 studies from 13 articles were finally included into the meta-analysis (12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 26, 27, 28) . The main characteristics of those 12 studies included in the meta-analysis are shown in Table 1 . Those 12 studies involved a total of 582 197 events of diabetes-associated mortality (12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 26, 27) . Of those 12 studies, there were five timeseries studies (12, 14, 19, 25, 26, 27) , five case-crossover studies (13, 15, 16, 17, 28) and two cohort studies (18, 20) . Four of these studies were from Canada (12, 14, 18, 19, 25) , four from USA (13, 16, 27, 28) , two from Italy (15, 17) , one from Denmark (20) and one from China (26) ( Table 1 ). All studies reported adjusted estimates, but the adjusted factors were of various types and different from each other ( Table 1) . There were five studies evaluating PM2.5 (18, 19, 25, 27, 28) , four studies evaluating PM10 (13, 15, 25, 26) , five studies evaluating NO 2 (14, 17, 19, 20, 26) , three studies evaluating SO 2 (14, 19, 26) , two studies evaluating O 3 (12, 16) and two studies evaluating CO (14, 19) respectively (Table 1) . According to the quality of criteria, there were two studies with an excellent quality (18, 20) and the other ten studies were of good quality (12, 13, 14, 15, 16, 17, 19, 25, 26, 27, 28) (Table 1 ).
PM2.5 and diabetes-associated mortality
Meta-analysis of those four studies (18, 19, 25, 27, 28) evaluating PM2.5 showed that a high level of PM2. Twelve studies from 13 articles included in meta-analysis PM2.5 (n = 5)
23 articles excluded Irrelevant outcomes (n = 17) Design not eligible (n = 6) Figure 1 Flow chart of study selection in the meta-analysis.
European Journal of Endocrinology
Review C Li and others Air pollution and diabetes 171:5 R185
www.eje-online.org 
www.eje-online.org P value for Egger's test was 0.127. When using the trim and fill method, no possible 'missing' study was added. (Fig. 3) .
PM10 and diabetes-associated mortality
Subgroup analyses by study design showed similar obvious associations (case-crossover studies 2: RRZ1.011, 95% CI 1.004-1.018, PZ0.002). There was no obvious risk of publication bias in the funnel plot for the association between PM10 and diabetes-associated mortality, and the P value for Egger's test was 0.150. When using the trim and fill method, two possible 'missing' studies were added, and a high level of PM10 was still significantly associated with an increased risk of diabetes-associated mortality (per 10 mg/m 3 : RRZ1.008, 95% CI 1.003-1.012, P!0.001). 
NO 2 and diabetes-associated mortality
Other air pollutants and diabetes-associated mortality
Meta-analysis of those three studies on SO 2 (14, 19, 26) indicated that a high level of SO 2 was not significantly associated with an increased risk of diabetes-associated mortality (per IQR increment: RRZ1.027, 95% CI 0.998-1.058, PZ0.070, I 2 Z66.9%).
Meta-analysis of those three studies on O 3 (12, 16) showed that a high level of O 3 was significantly associated with an increased risk of diabetes-associated mortality (per IQR increment: RRZ1.065, 95% CI 1.017-1.115, PZ0.007, I
2 Z0.0%).
Meta-analysis of those three studies on CO (14, 19) showed that a high level of CO was not significantly 
Figure 2
Association between the high level of PM2.5 and diabetesassociated mortality. 
Figure 3
Association between the high level of PM10 and diabetesassociated mortality.
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Discussion
Currently, there is no definite conclusion on the influence of air pollutants on diabetes-associated mortality. This study is a comprehensive meta-analysis aimed to assess the associations between main air pollutants and diabetes-associated mortality. Eleven studies involving a total of 582 197 events of diabetes-associated mortality were finally included in the meta-analysis (12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 26, 27, 28) . The findings from the meta-analysis suggested that an increased risk of diabetesassociated mortality was associated with increases in PM2. (Figs 2, 3 and 4) . Thus, the findings from the meta-analysis prove the obvious influence of air pollutants on diabetes-associated mortality and exposure to high levels of air pollutants results in an increased risk of diabetes-associated mortality.
In the present meta-analysis, the associations were first assessed by per IQR increment and then by standardised increment (per 10 mg/m 3 increment) for PM2.5, PM10 and NO 2 . However, the method described above was not used for the other three pollutants because there were limited studies and obviously discrepancy in the IQR for O 3 , SO 2 and CO. More studies are needed to assess the effects of O 3 , SO 2 and CO on the risk of diabetesassociated mortality. In addition, most included studies used generalised linear models to assess the associations of PM2.5, PM10 and NO 2 with diabetes-associated mortality; we thus used standardised risk estimates by a standardised increment in the pollutant concentration by 10 mg/m 3 each for PM2.5, PM10 and NO 2 . There was no obvious discrepancy in the pooled results of meta-analyses by different data types (per IQR or per 10 mg/m 3 ), which suggested the stability of overall risk estimates. The adverse effects of air pollution on cardiovascular disease, lung cancer and natural-cause mortality have been well established in several major epidemiological studies (5, 8, 10, 11, 29, 30) . The findings from the metaanalysis further add strong evidence for the adverse effect of air pollution on diabetes-associated mortality. In addition, there are also many studies showing the possible associations of air pollutants with the risk of diabetes (31, 32, 33, 34, 35) , which further indicate the adverse effects of air pollution on diabetes. The adverse effect of exposures to air pollution on diabetes-associated mortality is of much importance, given the extraordinary confluence of air pollutants worldwide (36) .
Air pollution is a more and more serious problem worldwide, especially in the developing or rapidly urbanising countries, such as China (36, 37, 38) . The adverse effect of exposure to air pollution on diabetesassociated mortality is of much more importance for those countries with serious air pollution. Air pollution in China is a significant public health burden, and the mean annual averages of PM2.5, PM10 and NO 2 among 74 major cities from China in 2013 were 72.4, 118.5 and 43.7 mg/m 3 (39), which were roughly fivefold higher than the USA National Ambient Air Quality Standard of 15 mg/m 3 for PM2.5 and the WHO standard of 10 mg/m 3 . Given the increasing burden of air pollution and its continuous and omnipresent nature, even a small adverse effect on health can represent an enormous public health issue and it should deserve rapid and positive response in public health policy. The findings from the meta-analysis provide strong evidence for the clear adverse effect of air pollution on diabetes-associated mortality, thus improvement of air quality through positive environmental policy or interventions are needed to gain public health benefits and substantial health-care cost savings. Several limitations of the meta-analysis should be considered when interpreting the results. First, most included studies were time-series studies or case-crossover 
Figure 4
Association between the high level of NO 2 and diabetesassociated mortality.
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www.eje-online.org studies, while only two studies used cohort design. To get a more precise assessment on the effects of main air pollutants on diabetes-associated mortality, more welldesigned studies with a large sample size are needed. Secondly, most studies included for the meta-analysis were done in developed countries, and there was only one study from the developing countries. However, the data from developing countries may be more concerning because these regions are affected mostly by air pollution and may have the greatest potential to improve health by controlling air pollution and improving air quality (40) . More studies from developing countries are needed to provide a more precise assessment of the influence of air pollution on diabetes-associated mortality. Finally, the potential additive effects of multiple pollutants on diabetes-associated mortality were not assessed owing to the lack of relevant data in those included studies. Future studies may further assess the possible additive effects of multiple pollutants on diabetes-associated mortality, which may help us better understand the adverse influence of air pollution on public health (41).
In conclusion, the findings from the meta-analysis suggest that exposure to high levels of air pollutants is significantly associated with an increased risk of diabetes-associated mortality. Higher levels of PM2.5, PM10, NO 2 and O 3 are all associated with the risk of diabetes-associated mortality. However, future studies are needed to further assess the effects of SO 2 and CO on the risk of diabetes-associated mortality. In addition, more well-designed studies with a large sample size are needed to provide a more precise assessment of the influence of air pollution on diabetes-associated mortality.
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